The aim, as before, is to provide guidance on the appropriateness, method and frequency of screening for people at moderate and high risk from colorectal cancer. This guidance provides some new recommendations for those with inflammatory bowel disease and for those at moderate risk resulting from ...
Colon cancer screening. The high risk patient.*Familial factors are associated with a significant proportion of colorectal cancer cases. In the general population, approximately 10 to 20% of individuals have a familial risk for colorectal cancer. If an individual has a first-degree relative (FDR)...
Screening strategies vary according to the individual risk of colon cancer. This paper will focus on the screening recommendations for patients with high-risk colon cancer. 展开 关键词: colon cancer colonoscopy family history personal history screening syndromic colon cancer ...
The experience with colorectal cancer at the Denver Veterans Administration Hospital was retrospectively reviewed to characterize the high-risk population with this disease and to determine what impact, if any, screening high-risk patients might have on overall survival rates. The high-risk patients com...
After colon cancer screening, large numbers of persons discovered with colon polyps may receive post-polypectomy surveillance with multiple colonoscopy exa... DF Ransohoff,B Yankaskas,Z Gizlice,... - 《Digestive Diseases & Sciences》 被引量: 138发表: 2011年 Primer: applying the new postpolypect...
Canto MI, Harinck F, Hruban RH, et al; International Cancer of Pancreas Screening (CAPS) Consortium. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut. 2013;62(3):339-347...
2,3 Thus, substantial decreases in cancer screening and diagnosis in 2020 have been described.4,5 Furthermore, previous work has shown the increased risk of worse outcomes for patients with cancer and COVID-19, especially in 2020, prior to the widespread availability of vaccinations. ...
Colorectal cancer is the third most common cause of cancer deaths in the United States and advanced colorectal polyps are a major risk factor. The U.S. Preventive Services Task Force (USPSTF) concluded that aspirin reduces the risk of colorectal cancer b
1 In 2012, the US Preventive Services Task Force recommended against routine prostate-specific antigen (PSA) screening owing to risk of overdiagnosis of clinically insignificant prostate cancer. Consequently, there has been a decrease in indolent, localized disease, but a concordant increase of ...
5b). Although genomics can routinely determine high-risk, predisposition and aspects related to tumour burden and recurrence, effective targeted cancer treatment is still not available for all cancers. For example, systematic genome-wide studies like the Pan-Cancer Analysis integrated analyses of >2600...